Ardelyx, Inc. (ARDX) is a publicly traded Healthcare sector company. As of October 20, 2026, ARDX trades at $3.09 with a market cap of $797.80M and a P/E ratio of -14.59. ARDX moved +0.00% today. Year to date, ARDX is -49.76%; over the trailing twelve months it is -38.57%. Its 52-week range spans $3.05 to $8.40. Analyst consensus is strong buy with an average price target of $13.43. Rallies surfaces ARDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ARDX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $3.09 |
| Market Cap | $797.80M |
| P/E Ratio | -14.59 |
| EPS | $-0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.40 |
| 52-Week Low | $3.05 |
| Volume | 37 |
| Avg Volume | 0 |
| Revenue (TTM) | $450.89M |
| Net Income | $-55.70M |
| Gross Margin | 94.37% |
7 analysts cover ARDX: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.43.